PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8489332

Ethics and the Human Genome Project.

S J Durfy
View original source ↗Export metadata ↓

Abstract

This article provides an overview of ethical issues in genetic testing and screening as they are currently considered in relationship to the Human Genome Project. Previous landmark reports and policy recommendations on genetic testing and screening are briefly described. The goals and research interests of the joint National Institutes of Health/Department of Energy Ethical, Legal, and Social Working Group of the Human Genome Project are outlined. To provide an example of one method by which ethical issues in genetics may be addressed, the ethical framework and practical aspects of a clinical ethics research project at the University of Washington, Seattle, are described. Finally, future directions for the study of ethical and social issues related to genetic testing and screening programs are suggested.

Explore related subjects

Advisory CommitteesEthical AnalysisEthics, MedicalFederal GovernmentGenetic Diseases, InbornGenetic TestingGenetics, MedicalGenome, HumanHuman Genome ProjectHumansBiomedical and Behavioral ResearchGenetics and ReproductionNIH-DOE Working Group on Ethical, Legal, and Social Issues (ELSI)University of WashingtonJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S J Durfy. 1993. Ethics and the Human Genome Project.. https://pubmed.ncbi.nlm.nih.gov/8489332/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2022

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.

Since the publication of the Revised European-American Classification of Lymphoid Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have been generated through iterative international efforts to achieve broad consensus among hematopathologists, geneticists, molecular scientists, and clinicians. Significant progress has recently been made in the characterization of malignancies of the immune system, with many new insights provided by genomic studies. They have led to this proposal. We have followed the same process that was successfully used for the third and fourth editions of the World Health Organization Classification of Hematologic Neoplasms. The definition, recommended studies, and criteria for the diagnosis of many entities have been extensively refined. Some categories considered provisional have now been upgraded to definite entities. Terminology for some diseases has been revised to adapt nomenclature to the current knowledge of their biology, but these modifications have been restricted to well-justified situations. Major findings from recent genomic studies have impacted the conceptual framework and diagnostic criteria for many disease entities. These changes will have an impact on optimal clinical management. The conclusions of this work are summarized in this report as the proposed International Consensus Classification of mature lymphoid, histiocytic, and dendritic cell tumors.

Advisory Committees↗